In a randomized, double-blind clinical trial that involved 33 AD patients who received either placebo or omega-3 preparation, Levi et al. [51] observed a link between cerebrospinal fluid DHA level and lowered markers of tau phosphorylation. Here, MAPT is linked to Alzheimer disease.